UNH CEO Forum Welcomes Tissuelink Medical CEO by Wright, Lori
University of New Hampshire
University of New Hampshire Scholars' Repository
Media Relations Administrative Offices
5-23-2006
UNH CEO Forum Welcomes Tissuelink Medical
CEO
Lori Wright
Follow this and additional works at: https://scholars.unh.edu/news
This News Article is brought to you for free and open access by the Administrative Offices at University of New Hampshire Scholars' Repository. It has
been accepted for inclusion in Media Relations by an authorized administrator of University of New Hampshire Scholars' Repository. For more
information, please contact nicole.hentz@unh.edu.
Recommended Citation
Wright, Lori, "UNH CEO Forum Welcomes Tissuelink Medical CEO" (2006). UNH Today. 1149.
https://scholars.unh.edu/news/1149
9/18/17, 10)42 AMUNH CEO Forum Welcomes Tissuelink Medical <acronym>CEO</acronym>
Page 1 of 1http://www.unh.edu/delete/news/cj_nr/2006/may/lw_060523forum.cfm@type=n.html
 
UNH CEO Forum Welcomes Tissuelink Medical CEO




DURHAM, N.H. -- Jackie Eastwood, president and CEO of TissueLink Medical of Dover, will
discuss how the company’s strong focus on the needs of customers has resulted in rapid
growth of the business at the next University of New Hampshire CEO Forum, Thursday, June
8, 2006.
“TissueLink Medical – The Story” begins at 8 a.m. at the New England Center with coffee and
breakfast, with the program commencing at 9 a.m.
Formed in 1999, TissueLink Medical is a private company in Dover that develops and markets
disposable surgical devices that reduce or eliminate bleeding in surgery. The company’s
products are used in 20 countries by surgeons to control bleeding in solid organ resections,
orthopedic reconstruction and spine surgery. The company’s proprietary technology can apply
to multiple surgical specialties addressing markets that exceed $3.5 billion.
Jackie Eastwood, president and CEO of TissueLink Medical, was named the 2004 Ernst &
Young New England Entrepreneur Of The Year in the medical devices category. Eastwood's
philosophy behind the growth of TissueLink has been to deeply understand the needs of its
customers, both medical practitioners and patients, in developing and manufacturing
technology to seal tissue and reduce bleeding. The model has driven rapid product
development with deep surgeon acceptance and an overall recognition by customers of
TissueLink's dedication to them and their patients. The model has also been validated by the
success of their technology: in just two years TissueLink captured more than 25 percent of
U.S. liver resection procedures and has become the new "gold standard" for liver surgery.
TissueLink is expanding its procedural applications, with a strong focus on orthopedic surgery.
To register or to become a member of the CEO Forum, call Barbara Draper at (603) 862-1107,
or e-mail her at barbara.draper@unh.edu.The registration deadline is Thursday, June 1.
Initiated in 1997, the CEO Forum is an outreach program of the UNH Whittemore School of
Business and Economics and the UNH Graduate School serving CEOs, presidents, and senior
managers of companies in northern New England. The forum provides its members with
opportunities to meet and exchange ideas with their peers in business and industry in an
informal setting. The CEO Forum is sponsored by the law firm of Pierce Atwood and Ocean
National Bank. For more information about the CEO Forum, visit http://www.unh-
ceoforum.org/.
